THBS4
Basic information
Region (hg38): 5:79991311-80083287
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the THBS4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 60 | 63 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 60 | 2 | 3 |
Variants in THBS4
This is a list of pathogenic ClinVar variants found in the THBS4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-80035620-C-G | not specified | Uncertain significance (Feb 11, 2022) | ||
5-80040079-T-C | not specified | Uncertain significance (Jun 24, 2022) | ||
5-80040121-G-A | not specified | Uncertain significance (Mar 06, 2023) | ||
5-80040134-T-C | not specified | Uncertain significance (Apr 05, 2023) | ||
5-80040146-C-T | not specified | Uncertain significance (Dec 21, 2022) | ||
5-80040167-T-G | not specified | Uncertain significance (Dec 21, 2023) | ||
5-80040188-A-G | not specified | Uncertain significance (Apr 07, 2022) | ||
5-80040269-G-A | not specified | Uncertain significance (Jun 17, 2024) | ||
5-80055787-A-G | not specified | Uncertain significance (Feb 01, 2023) | ||
5-80055793-C-T | not specified | Uncertain significance (Mar 30, 2024) | ||
5-80055865-C-T | not specified | Uncertain significance (Mar 30, 2024) | ||
5-80055880-A-G | not specified | Uncertain significance (Dec 06, 2022) | ||
5-80055890-A-G | not specified | Uncertain significance (Oct 03, 2024) | ||
5-80055899-G-A | not specified | Uncertain significance (Dec 10, 2024) | ||
5-80055915-A-G | Benign (Mar 29, 2018) | |||
5-80055967-G-A | not specified | Uncertain significance (Jul 25, 2023) | ||
5-80056031-A-G | not specified | Uncertain significance (Apr 11, 2023) | ||
5-80058209-T-C | not specified | Uncertain significance (Dec 08, 2023) | ||
5-80058287-A-T | not specified | Uncertain significance (Sep 30, 2024) | ||
5-80058299-G-A | not specified | Uncertain significance (Nov 01, 2022) | ||
5-80058718-C-G | not specified | Uncertain significance (Oct 28, 2024) | ||
5-80058720-G-A | not specified | Uncertain significance (Oct 25, 2024) | ||
5-80058737-A-G | not specified | Uncertain significance (Nov 10, 2022) | ||
5-80058776-C-T | not specified | Uncertain significance (Mar 02, 2023) | ||
5-80059462-G-A | not specified | Uncertain significance (Nov 10, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
THBS4 | protein_coding | protein_coding | ENST00000350881 | 22 | 91977 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.51e-18 | 0.689 | 125521 | 2 | 225 | 125748 | 0.000903 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.21 | 474 | 554 | 0.856 | 0.0000310 | 6377 |
Missense in Polyphen | 216 | 264.8 | 0.81571 | 3120 | ||
Synonymous | -0.0513 | 229 | 228 | 1.00 | 0.0000143 | 1819 |
Loss of Function | 2.01 | 36 | 51.6 | 0.698 | 0.00000275 | 549 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00310 | 0.00309 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.00169 | 0.00163 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000877 | 0.000871 |
Middle Eastern | 0.00169 | 0.00163 |
South Asian | 0.000198 | 0.000196 |
Other | 0.00147 | 0.00147 |
dbNSFP
Source:
- Function
- FUNCTION: Adhesive glycoprotein that mediates cell-to-cell and cell-to-matrix interactions and is involved in various processes including cellular proliferation, migration, adhesion and attachment, inflammatory response to CNS injury, regulation of vascular inflammation and adaptive responses of the heart to pressure overload and in myocardial function and remodeling. Binds to structural extracellular matrix (ECM) proteins and modulates the ECM in response to tissue damage, contributing to cardioprotective and adaptive ECM remodeling. Plays a role in ER stress response, via its interaction with the activating transcription factor 6 alpha (ATF6) which produces adaptive ER stress response factors and protects myocardium from pressure overload. May contribute to spinal presynaptic hypersensitivity and neuropathic pain states after peripheral nerve injury. May play a role in regulating protective astrogenesis from the subventricular zone (SVZ) niche after injury in a NOTCH1-dependent manner (By similarity). {ECO:0000250, ECO:0000269|PubMed:19441079}.;
- Pathway
- PI3K-Akt signaling pathway - Homo sapiens (human);ECM-receptor interaction - Homo sapiens (human);Focal adhesion - Homo sapiens (human);Phagosome - Homo sapiens (human);Malaria - Homo sapiens (human);Human papillomavirus infection - Homo sapiens (human);Focal Adhesion;Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;PI3K-Akt Signaling Pathway;Signal Transduction;Signaling by PDGF;Signaling by Receptor Tyrosine Kinases
(Consensus)
Recessive Scores
- pRec
- 0.340
Intolerance Scores
- loftool
- 0.180
- rvis_EVS
- -0.24
- rvis_percentile_EVS
- 36.32
Haploinsufficiency Scores
- pHI
- 0.190
- hipred
- N
- hipred_score
- 0.488
- ghis
- 0.441
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.170
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Thbs4
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); homeostasis/metabolism phenotype; growth/size/body region phenotype; muscle phenotype;
Zebrafish Information Network
- Gene name
- thbs4b
- Affected structure
- muscle
- Phenotype tag
- abnormal
- Phenotype quality
- detached from
Gene ontology
- Biological process
- positive regulation of endothelial cell proliferation;response to unfolded protein;regulation of signaling receptor activity;negative regulation of angiogenesis;regulation of tissue remodeling;response to endoplasmic reticulum stress;behavioral response to pain;tissue remodeling;positive regulation of peptidyl-tyrosine phosphorylation;myoblast migration;positive regulation of cell division;endothelial cell-cell adhesion;positive regulation of neutrophil chemotaxis
- Cellular component
- extracellular region;basement membrane;extracellular space;endoplasmic reticulum;sarcoplasmic reticulum;collagen-containing extracellular matrix;extracellular exosome
- Molecular function
- integrin binding;calcium ion binding;protein binding;growth factor activity;heparin binding